| |
Sensex ends 274 points lower, Nifty50 below 7,650; Vedanta sheds 5%
The domestic equity market saw a fresh bout of selling on Wednesday as investors grew increasingly concerned about a ... |
Worried about volatility? Top wealth-creating ideas for next 12 months
One of the prominent factors would be the impending rate hike by the US Federal Reserve, whose tremors would be felt ... |
Turbulence in black gold, the biggest risk for 2016 is already here
Long-term oil price bears Goldman Sachs reckon that any thought of a rebound or even stabilization in 2016 are way of... |
| |
| |
| |
 |
| FROM THE NEWSPAPER |
| Alkem Laboratories $200 million IPO fully subscribed Alkem had received orders for about 11.8 million shares, or about 1.3 times the number of shares being offered as of ... |
| Dr Lal PathLabs IPO oversubscribed Dr Lal PathLabs' initial public offer was oversubscribed 1.08 times till afternoon on the second day of the issue tod... |
| Top five stock ideas from foreign brokerages for lacklustre market Different brokerages, came out with these recommendations this week in separate notes to their clients.... |
| GST is important, but won't alter market course: Gautam Chhaochharia, UBS India Chhaochharia says that FIIs in the US and the Europe are less worried about India's near term growth expectations com... |
| Retail rush for tax-free bonds like IRFC continues The tax-free bond issue by Indian Railways Finance Corp (IRFC) was subscribed 2.38 times on the first day led by stro... |
MORE LINKS:Gainers |Losers|Movers|Only Buyers|Only Sellers|Surging Volumes|Indices |
|
| More Newsletters |
|
| |  | ET Mutual Fund
A weekly round-up of the top news and views from the mutual fund industry. | |  | | |  | Wealth
Weekly news on personal finance, stocks, property, gold, tax planning and more. | | | |
| |
| |
To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today.
If you are having trouble viewing this newsletter, please click here |
| To unsubscribe or edit your subscriptions please click here |
No comments:
Post a Comment